Sherry Pierce

Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia.

Stefano Sacchi, Hagop M. Kantarjian, Stephen O’Brien et al. · Journal of Clinical Oncology · 1995 · 170 citations · Full text

Medicine, Hematology, Immunology +15

Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term Survival

Francis J. Giles, Yu Shen, Hagop M. Kantarjian et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 146 citations

Medicine, Oncology, Cell Therapy +9

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

Susan O’Brien, Deborah A. Thomas, Farhad Ravandi et al. · Cancer · 2008 · 133 citations · Full text

Medicine, Oncology, Pharmacology +10

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Constantine S. Tam, Hagop M. Kantarjian, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2009 · 118 citations

Medicine, Hematology, Pathology +17

Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.

H. Kantarjian, M Keating, Elihu Estey et al. · Journal of Clinical Oncology · 1992 · 114 citations

Medicine, Hematology, Pharmacotherapy +12